![]() |
市场调查报告书
商品编码
1715166
2031年北美间歇导管市场预测-区域分析-依产品、适应症、类别、系统类型及最终用户North America Intermittent Catheters Market Forecast to 2031 - Regional Analysis - by Product, Indication, Category, System Type, and End User |
2023年北美间歇导管市值为10.3579亿美元,预计到2031年将达到15.0664亿美元;预计2023年至2031年的复合年增长率为4.8%。
尿失禁盛行率飙升推动北美间歇导尿管市场发展
尿失禁(UI)是影响全球大量人口最常见的问题。在更严重的情况下,它会导致偶尔或轻微的漏尿或无法控制的慢性排尿。肥胖症的盛行率日益增加;老年人口不断增加;前列腺癌、糖尿病、肾臟疾病和多发性硬化症等慢性疾病的发生率上升是 UI 的主要危险因子。脊髓损伤、脑性麻痹、摄护腺增大、多发性硬化症和癌症等疾病可能会导致老年族群出现 UI。
随着全球老龄人口的激增,失业保险对医疗保健系统的经济负担也随之增加。根据世界卫生组织(WHO)的数据,2020年全球60岁以上人口总数为10亿,预计2031年将达到14亿人。根据梅奥诊所健康系统2023年发表的一篇文章,尿液不受控制地漏出是一种常见症状,影响着几乎50%的老年人口。这种疾病的盛行率随着年龄的增长而增加,且任何年龄层的女性盛行率都高于男性; 65岁以上的女性中,高达75%的人患有漏尿。每天数次将间歇性导尿管通过尿道插入患者的膀胱,将尿液排出体外;它会在膀胱中保留足够长的时间以排出膀胱中的液体,然后再将其取出。透过导尿,人们可以更好地控制膀胱。一旦膀胱排空并移除导尿管,人们就可以继续他们的日常活动,而不会受到任何阻碍和尴尬。因此,UI 的盛行率不断上升正在推动间歇导管市场的成长。
北美间歇导管市场概览
根据人口参考局的数据,2023 年 65 岁及以上人口数为 5,800 万,预计到 2050 年将增加到 8,200 万。这一老化人口更容易受到脊髓损伤 (SCI)、尿失禁和良性前列腺增生的影响。例如,根据疾病管制与预防中心的数据,尿失禁是 65 岁或以上族群的主要症状,原因多种多样,包括糖尿病和中风等慢性疾病、认知障碍和发病率障碍。此外,根据美国国家脊髓损伤统计中心的估计,美国每年有 17,500 人患有脊髓损伤,尤其是老年族群。脊髓损伤患者主要需要导尿来控制神经性膀胱功能障碍,其中主要使用导尿管。因此,预计导尿管使用量的不断增长将推动该国导尿管市场的成长。
北美间歇导管市场收入及预测(2031 年)(百万美元)
北美间歇导管市场细分
北美间歇导管市场分为产品、适应症、类别、系统类型、最终用户和国家。
根据产品,北美间歇导管市场分为涂层间歇导管和无涂层间歇导管。 2023 年,涂层间歇导管部分占据了北美间歇导管市场的较大份额。
就适应症而言,北美间歇性导管市场分为尿失禁、普通手术、脊髓损伤、帕金森氏症 (pd)、多发性硬化症等。 2023 年,尿失禁领域占据北美间歇导管市场的最大份额。
根据类别,北美间歇导管市场包括女性长度导管、男性长度导管和儿童长度导管。 2023 年,女性长度导管占据北美间歇导管市场的最大份额。
根据系统类型,北美间歇导管市场分为封闭式间歇导管系统和开放式间歇导管系统。 2023 年,封闭式间歇导管系统部分占据了北美间歇导管市场的较大份额。
就最终用户而言,北美间歇导管市场分为医院、门诊手术中心、家庭护理机构和其他。 2023 年,医院部门占据北美间歇导管市场的最大份额。
根据国家/地区,北美间歇导管市场分为美国、加拿大和墨西哥。 2023 年,美国占据北美间歇导管市场的最大份额。
Advin Health Care Pvt Ltd; B 布劳恩 SE;波士顿科学公司;康德乐健康公司;康乐保公司;康维泰克集团股份有限公司;霍利斯特公司;佐治亚医疗技术公司; Teleflex 公司;和 Wellspect HealthCare 是北美间歇性导管市场的一些领先公司。
The North America intermittent catheters market was valued at US$ 1,035.79 million in 2023 and is expected to reach US$ 1,506.64 million by 2031; it is estimated to register a CAGR of 4.8% from 2023 to 2031.
Surging Prevalence of Urinary Incontinence Fuels North America Intermittent Catheters Market
Urinary incontinence (UI) is the most common problem affecting a substantial global population. It results in occasional or minor leaking or uncontrolled chronic urination, in worse cases. The growing prevalence of obesity; the increasing geriatric population; and the rising incidence of chronic diseases such as prostate cancer, diabetes, kidney diseases, and multiple sclerosis are among the prime risk factors for UI. Medical conditions such as spinal cord injuries, cerebral palsy, prostate enlargement, multiple sclerosis, and cancer, among others, may lead to UI in the geriatric population.
The economic burden of UI on healthcare systems grows with the surging elderly population across the world. According to the World Health Organization (WHO), the total population aged 60 and above was 1 billion in 2020, and it is expected to reach 1.4 billion by 2031. According to an article published by Mayo Clinic Health System in 2023, the uncontrolled leakage of urine is a common symptom that affects almost 50% of the elderly population. The prevalence of this condition increases with age, and it affects more women than men of any age; up to 75% of women over 65 suffer from urine leakage. Intermittent urinary catheters are inserted into the bladder of individuals through the urethra several times a day to carry urine out of their body; it is kept in the bladder for just long enough to drain it before removing it. By catheterizing themselves, people can gain better control over their bladder. Once the catheter is removed after the bladder is emptied, people can continue their daily activities without any hindrances and awkwardness. Thus, the rising prevalence of UI is driving the growth of the intermittent catheters market.
North America Intermittent Catheters Market Overview
According to the Population Reference Bureau, the number of people aged 65 and above was 58 million in 2023 and it is estimated to increase to 82 million by 2050. This aging population is more susceptible to spinal cord injury (SCI), urinary incontinence, and benign prostate hyperplasia. For instance, according to the Centers for Disease Control and Prevention, urinary incontinence is a major symptom among people aged 65 or above due to various factors, including chronic conditions such as diabetes and stroke, cognitive impairment, and morbidity impairment. Moreover, according to the National Spinal Cord Injury Statistical Center, it was estimated that each year, 17,500 people were suffering from SCI in the US, especially among the geriatric population. Patients affected by SCI majorly need the help of urinary catheterization to control neurogenic bladder dysfunction, where urinary catheters are mainly used. Thus, the growing use of urinary catheters is expected to fuel the growth of the urinary catheters market in the country.
North America Intermittent Catheters Market Revenue and Forecast to 2031 (US$ Million)
North America Intermittent Catheters Market Segmentation
The North America intermittent catheters market is categorized into product, indication, category, system type, end user, and country.
By product, the North America intermittent catheters market is segmented into coated intermittent catheters and uncoated intermittent catheters. The coated intermittent catheters segment held a larger share of the North America intermittent catheters market share in 2023.
In terms of indication, the North America intermittent catheters market is segmented into urinary incontinence, general surgeries, spinal cord injuries, Parkinson's Disease (pd), multiple sclerosis, and others. The urinary incontinence segment held the largest share of the North America intermittent catheters market share in 2023.
Based on category, the North America intermittent catheters market is female length catheters, male length catheters, and kid length catheters. The female length catheters segment held the largest share of the North America intermittent catheters market share in 2023.
By system type, the North America intermittent catheters market is bifurcated into closed intermittent catheters systems and open intermittent catheters systems. The closed intermittent catheters systems segment held a larger share of the North America intermittent catheters market share in 2023.
In terms of end user, the North America intermittent catheters market is segmented into hospitals, ambulatory surgical centers, home care settings, and others. The hospitals segment held the largest share of the North America intermittent catheters market share in 2023.
Based on country, the North America intermittent catheters market is segmented into the US, Canada, and Mexico. The US segment held the largest share of North America intermittent catheters market in 2023.
Advin Health Care Pvt Ltd; B Braun SE; Boston Scientific Corp; Cardinal Health Inc; Coloplast Corp; Convatec Group Plc; Hollister Inc; Medical Technologies of Georgia, Inc.; Teleflex Inc; and Wellspect HealthCare are some of the leading companies operating in the North America intermittent catheters market.